spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  S.A. 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 25 Oct 2024
Lilly's EBGLYSS(TM) (lebrikizumab-lbkz) Demonstrated Meaningful Improvement in Skin Clearance and Itch Relief in the Majority of Patients with Moderate-To-Severe Atopic Dermatitis Who Discontinued Dupilumab
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 31 Aug 2023
Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Dec 2022
Hyphens Pharma Licenses Winlevi(R) for All 10 ASEAN countries from Cosmo Pharmaceuticals
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 3 Nov 2022
Grifols Receives FDA Clearance for Alphaid(TM) At Home, the First Free Service for U.S. Consumers to Determine Their Risk for Alpha-1
Diagnostics FDA
 HSMN NewsFeed - 28 Sep 2022
Harrow Announces U.S. FDA Approval of IHEEZO(TM) (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 22 Aug 2022
Endo Tools Therapeutics Announces First U.S. Commercial Cases of The Endomina(R) System
Devices Gastroenterology Surgery
 HSMN NewsFeed - 7 Jun 2022
Eight out of Ten Patients Maintained Skin Clearance at One Year in Lilly's Lebrikizumab Atopic Dermatitis Monotherapy Trials
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 1 Feb 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 18 Jan 2022
Endomina(R) System, a New Suturing Tool for Use by Gastroenterologists Receives FDA Clearance
Devices Gastroenterology FDA
 HSMN NewsFeed - 21 Dec 2021
Lilly's lebrikizumab demonstrated significant skin improvement and itch relief when combined with topical corticosteroids in people with atopic dermatitis in third Phase 3 study
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 27 Oct 2021
HT Supreme(R) Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Aug 2021
Lilly's lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase 3 trials
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 10 Aug 2021
LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 while Advancing Portfolio Assets
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 19 Jul 2021
Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2021
THINK Surgical and Ortho Development Announce FDA Clearance for Use of Balanced Knee System and BKS TriMax Implants with TSolution One Total Knee Application Active Robot System
Devices Orthopaedic FDA
 HSMN NewsFeed - 8 Apr 2021
MolecuLight Announces the Appointment of 11 Global Distributors
Devices Wound Care Distribution
 HSMN NewsFeed - 5 Mar 2021
Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy
Devices Oncology FDA
 HSMN NewsFeed - 3 Feb 2021
Almirall announces Gianfranco Nazzi as new CEO
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 26 Jan 2021
Connect Biopharma Strengthens Leadership Team with Key Hire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jan 2021
GT Biopharma Appoints Two New Independent Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Dec 2020
Almirall announces FDA approval of Klisyri(R) (tirbanibulin), a new innovative topical treatment for actinic keratosis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 1 Dec 2020
Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business
Devices Acquisitions
 HSMN NewsFeed - 11 Nov 2020
Pablo Alvarez appointed to President and GM of Almirall US
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2020
Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 May 2020
GI Supply Launches New Device to Reduce Necrotic Tissue and Pancreatic Blood Fluids
Devices Surgery Product Launch
 HSMN NewsFeed - 27 Apr 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS(R) (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Aug 2019
SofWave Medical Closes $8.4M Financing Round; Announces Appointment of Louis Scafuri to CEO Position
Devices Dermatology Venture Capital Personnel
 HSMN NewsFeed - 2 Jul 2019
InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2019
FDA Premarket Approval Granted for DT MedTech's Hintermann Series H3(TM) Total Ankle Replacement System
Devices Orthopaedic FDA
 HSMN NewsFeed - 17 May 2019
U.S. FDA Approves GATTEX(R) (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 13 May 2019
Smith & Nephew launches new FLOW 90(TM) Wand at ISAKOS joining its innovative collection of COBLATION(TM) technology and shoulder repair portfolios
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 15 Mar 2019
Fujifilm Launches Three New Software Tools For Its ASPIRE Cristalle Digital Mammography System
Devices Radiology Oncology Product Launch
 HSMN NewsFeed - 24 Oct 2018
Inova Diagnostics Launches First FDA Cleared Calprotectin Extraction Device
Devices Diagnostics FDA Product Launch
 HSMN NewsFeed - 21 Sep 2018
Almirall acquires Allergan U.S. medical dermatology portfolio*
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 16 Aug 2018
Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins
Biopharmaceuticals Diagnostics FDA
 HSMN NewsFeed - 14 Aug 2018
Inova Diagnostics Receives FDA Clearance for Test to Detect Antibodies to HMGCR
Diagnostics FDA
 HSMN NewsFeed - 10 Aug 2018
Nuvo Pharmaceuticals(TM) Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 6 Aug 2018
AOBiome Therapeutics Announces the Expansion of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2018
MEDICALgorithmics, Medi-Lynx Receive FDA 510(K) Clearance for PocketECG CRS Mobile Cardiac Rehabilitation System
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 23 Jul 2018
Sangamo Therapeutics to Acquire TxCell
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Jul 2018
enGene Appoints Veteran Life Sciences Executive Jason D. Hanson as Chief Executive Officer and President
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 22 Jun 2018
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 May 2018
FDA approves additional claim for Roche cobas Zika test
Diagnostics FDA
 HSMN NewsFeed - 23 Apr 2018
Amerigen and Dipharma Announce U.S. FDA Approval for Generic Miglustat 100 mg Capsules
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 9 Apr 2018
RegeneRx Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 9 Apr 2018
Elekta Strengthens Presence in Mexico With Government Tender for Radiation Therapy Technology
Devices Oncology
 HSMN NewsFeed - 4 Apr 2018
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Mar 2018
Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Feb 2018
Johnson & Johnson Medical Devices Companies Acquire Orthotaxy to Develop Next-Generation Robotic-Assisted Surgery Platform in Orthopaedics
Devices Mergers & Acquisitions
 HSMN NewsFeed - 14 Feb 2018
Plastic And Reconstructive Surgery Journal Publishes Ten-Year Clinical Study Data Highlighting Safety Of MENTOR(R) MemoryShape(R) Gel Breast Implants
Devices Surgery
 HSMN NewsFeed - 12 Feb 2018
ImmunoMet Appoints Vincent J. O'Neill, M.D., B.Sc., M.R.C.P, as Chief Medical Officer, and Allan L. Shaw as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Feb 2018
closerlook, inc. names Steve Tulk as Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2018
Grifols HyperRAB(R) (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Feb 2018
Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 3 Jan 2018
Inova Diagnostics Receives FDA Clearance for the First Fully Automated, Random Access Calprotectin Test
Diagnostics FDA
 HSMN NewsFeed - 11 Dec 2017
OncoTartis Closes $6M Financing Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 6 Dec 2017
Forty Seven Inc. Receives $5 Million Grant from The California Institute for Regenerative Medicine (CIRM) to Support Ongoing Clinical Trial in Acute Myeloid Leukemia
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 22 Nov 2017
New Canon Digital Radiography Systems to be Showcased at RSNA Annual Meeting, Highlighting Ergonomic Design
Devices Radiology Product Launch
 HSMN NewsFeed - 4 Oct 2017
New Breast Implant For Patients Undergoing Breast Reconstruction, Augmentation Or Revision Surgery
Devices Product Launch
 HSMN NewsFeed - 28 Aug 2017
MedGenome Secures $30 Million Series C Funding Led by Sequoia India and Sofina
Diagnostics Venture Capital
 HSMN NewsFeed - 11 Jul 2017
DelMar Pharmaceuticals Appoints Saiid Zarrabian to the Board of Directors and Names Dr. Erich Mohr as Chairman
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 May 2017
Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Apr 2017
MENTOR(R) Launches MENTORPromise Protection Plan
Devices Product Launch
 HSMN NewsFeed - 17 Apr 2017
Merrimack Appoints Daryl Drummond, Ph.D. as Head of Research
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Apr 2017
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 28 Mar 2017
Introducing PROMETHEUS(R) IBcause(TM): Convenient All-in-One Diagnostic Test for Persistent Diarrhea
Diagnostics Gastroenterology Product Launch
 HSMN NewsFeed - 10 Mar 2017
Tris Pharma Appoints New Chief Commercial Officer for Brand Business
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 27 Feb 2017
Pharma Two B Ltd. Closes $30 Million Financing Round
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 19 Jan 2017
E-QURE Signs Distribution Agreement for its Breakthrough Wound Care Device for Colombia
Devices Wound Care Distribution
 HSMN NewsFeed - 18 Jan 2017
Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Mexico
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Dec 2016
Apricus Biosciences Announces the Launch of Vitaros(R) for the Treatment of Erectile Dysfunction in Lebanon by Elis Pharmaceuticals
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 19 Dec 2016
Aralez Announces Commercial Launch Of BLEXTEN(TM) In Canada
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 8 Dec 2016
Advanced Accelerator Applications Announces CMS Pass-Through Reimbursement Code for its First FDA Approved Drug NETSPOT(R)
Biopharmaceuticals Radiology Oncology Reimbursement
 HSMN NewsFeed - 18 Nov 2016
Apricus Biosciences Provides Update on Vitaros NDA Following Receipt of FDA Feedback
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 11 Nov 2016
OncBioMune Broadens Portfolio, Partners and Product with Vitel Acquisition
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 27 Sep 2016
IBA's Proton Therapy Community Achieves the Next Big Milestone With 50,000 Cancer Patients Treated
Devices Oncology
 HSMN NewsFeed - 27 Sep 2016
Upsher-Smith Enters into Exclusive Development and Distribution Agreement with Pharmathen S.A.
Biopharmaceuticals Distribution
 HSMN NewsFeed - 23 Sep 2016
IBA to Open the Path Towards Adaptive Proton Therapy
Devices Oncology
 HSMN NewsFeed - 20 Sep 2016
KVK Tech Announces FDA-Approval of Lomaira(TM) (phentermine hydrochloride USP) 8 mg tablets, CIV, A Low-Cost, Low-Dose Phentermine That Can Be Used Up To Three Times Daily for Weight Reduction
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Sep 2016
Advanced Accelerator Applications Announces Revised EMA Review Timeline for Lutathera(R)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 Aug 2016
Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep(R) Oral Solution And Confirms Patent Challenge For Generic Version Of Mirvaso(R) Gel
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 18 Aug 2016
Avelas Biosciences Completes $20 Million Series C Financing
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 25 Jul 2016
Apricus Biosciences Further Expands Existing Vitaros(R) Partnership with Ferring Pharmaceuticals in Europe and Asia
Biopharmaceuticals Distribution
 HSMN NewsFeed - 28 Jun 2016
iSTAR Medical Strengthens Board With Two Senior Appointments
Devices Ophthalmology Personnel
 HSMN NewsFeed - 21 Jun 2016
Perrigo Announces FDA Clearance And Launch Of Non-GMO* Infant Formulas For The U.S. Store Brand Market
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 21 Jun 2016
Alexza Pharmaceuticals Acquired by Ferrer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Jun 2016
ARIAD Announces Distribution Agreements for Iclusig(R) in Latin America and the Middle East/North Africa
Biopharmaceuticals Distribution
 HSMN NewsFeed - 14 Jun 2016
Suneva Medical Closes $25 Million Financing To Support Continued Growth Opportunities
Devices Dermatology Venture Capital
 HSMN NewsFeed - 2 Jun 2016
ARIAD Completes the Sale of Its European Operations and Out-License of European Rights to Iclusig(R)
Biopharmaceuticals Oncology Licensing Acquisitions
 HSMN NewsFeed - 2 Jun 2016
FDA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio 1143 in the Treatment of Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 31 May 2016
Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 26 May 2016
TransMedics, Inc. Announces Closing of $51.2 Million Growth Financing to Transform Organ Transplant Therapy
Devices Venture Capital
 HSMN NewsFeed - 10 May 2016
Alexza Pharmaceuticals to be Acquired by Ferrer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Apr 2016
Aralez Receives Health Canada Approval For BLEXTEN(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Apr 2016
Alma Surgical to Launch the 2nd Generation Femilift, the Femilift Smart, a New Robotic Probe for Advanced Precision & Faster Treatment of Feminine Health Concerns
Devices Product Launch
 HSMN NewsFeed - 19 Apr 2016
DalCor Pharmaceuticals Completes $150 Million Financing
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 4 Apr 2016
First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON(R) (sulfur hexafluoride lipid-type A microspheres) for Injectable Suspension, for Intravenous Use
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 31 Mar 2016
ContraVir Pharmaceuticals Appoints John Cavan as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Mar 2016
Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 24 Feb 2016
Forty Seven Inc. Completes $75M Series A Financing and Licenses Technology from Stanford University to Advance Next Generation Immuno-Oncology Programs
Biopharmaceuticals Oncology Venture Capital Licensing
 HSMN NewsFeed - 22 Feb 2016
Cipher Pharmaceuticals Inc. announces Canadian launch of Actikerall(TM)
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 16 Feb 2016
Mentor Receives FDA IDE Approval for its ATHENA Clinical Trial
Devices FDA
 HSMN NewsFeed - 20 Jan 2016
Allan L. Shaw Joins Syndax Pharmaceuticals As Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Jan 2016
Galderma Laboratories, L.P. Appoints Miles Harrison as Leader of U.S. and Canada
Biopharmaceuticals Devices Dermatology Personnel
 HSMN NewsFeed - 18 Dec 2015
Navitor Pharmaceuticals Announces $33 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Dec 2015
Allena Pharmaceuticals Raises $53 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Nov 2015
Lannett Completes Major Acquisition Of Kremers Urban Pharmaceuticals For $1.23 Billion
Biopharmaceuticals Generic Mergers & Acquisitions
 HSMN NewsFeed - 10 Nov 2015
Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences
Devices Interventional Radiology Oncology Acquisitions
 HSMN NewsFeed - 3 Nov 2015
TransEnterix, Inc. Appoints Steven Boudrez as Vice President of Sales, Europe
Devices Surgery Personnel
 HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 19 Aug 2015
Immunomedics Appoints Arthur S. Kirsch as Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jul 2015
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2015
GenSight Biologics Closes $36 Million Series B Preferred Stock Financing
Biopharmaceuticals Ophthalmology Venture Captial
 HSMN NewsFeed - 21 May 2015
Tris Pharma Announces the FDA Acceptance of NDA for Dyanavel(TM) XR
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 23 Apr 2015
Jounce Therapeutics Secures $56 Million in Oversubscribed Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 13 Apr 2015
Takeda Announces Appointment of New President of U.S. Business Unit
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2015
Third Rock Ventures Launches REVOLUTION Medicines with $45 Million Series A to Redesign Evolution’s Products to Treat Serious Diseases
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Jan 2015
Cohera Medical, Inc.(R) Enters Agreement with B. Braun Surgical, S.A. for Distribution of TissuGlu(R) Surgical Adhesive in Select European Countries
Devices Surgery Distribution
 HSMN NewsFeed - 7 Jan 2015
Philips receives FDA 510(k) clearance for its latest Avalon CL Fetal Monitoring solution
Devices Monitoring FDA
 HSMN NewsFeed - 5 Dec 2014
Bellicum Announces New Director, Executive Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2014
New Hire Announcement - Vice President Of Sales And Business Development
Devices Urology Personnel
 HSMN NewsFeed - 18 Nov 2014
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2014
Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of Selling ASCEND's EstroGel(R)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 16 Sep 2014
First-In-Man Study of the COBRA PzF(TM) Coronary Stent Shows Promising Results Highlighted by Short, 30-Day Dual-Antiplatelet Therapy and Low, 3% TLR Rate
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Aug 2014
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
Biopharmaceuticals Dermatology Venture Capital Personnel
 HSMN NewsFeed - 6 Aug 2014
Nodality Expands Senior Leadership Team, Appoints Kathleen LaPorte as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2014
Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market
Biopharmaceuticals Distribution
 HSMN NewsFeed - 30 Jul 2014
invendo medical Appoints Nachum (Homi) Shamir to the Company's Board of Directors
Devices Gastroenterology Personnel
 HSMN NewsFeed - 26 Jun 2014
Tris Pharma Expands R&D Team with addition of Chief Medical Officer and Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2014
ERBA Diagnostics, Inc. Appoints William Creech as Vice President Sales and Marketing
Diagnostics Personnel
 HSMN NewsFeed - 19 Jun 2014
Takeda Announces Termination of Orteronel (TAK-700) Development for Prostate Cancer in Japan, U.S.A. and Europe
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Jun 2014
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 May 2014
Genkyotex Announces New Senior Management and Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2014
Proteon Therapeutics Announces $45 Million of Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 May 2014
MediWound Expands Distribution of NexoBrid to Russia Through Agreement With Genfa Medica
Biopharmaceuticals Wound Care Distribution
 HSMN NewsFeed - 30 Apr 2014
FDA Approves New Liquid Form Of Treatment For Patients With Acute Lymphoblastic Leukemia (ALL) As Part Of A Combination Regimen
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Apr 2014
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 8 Apr 2014
Takeda Responds to Verdict in Diabetes Drug Case
Biopharmaceuticals Endocrinology Litigation
 HSMN NewsFeed - 7 Apr 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Diversified, High-Growth Specialty Pharmaceuticals Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Mar 2014
CeloNova’s Coronary Stent System Could Mean Faster Healing of Arteries and Greatly Reduced Use of Blood-thinning Medication
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 26 Feb 2014
Nodality, Inc. Appoints Ralph Snyderman, M.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2014
Bioventus Acquires DUROLANE(R) assets from Galderma
Devices Orthopaedic Acquisitions
 HSMN NewsFeed - 17 Jan 2014
Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene(TM) AMD test in North America
Diagnostics Ophthalmology Licensing
 HSMN NewsFeed - 14 Jan 2014
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America
Biopharmaceuticals Neurology Distribution
 HSMN NewsFeed - 8 Jan 2014
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 13 Dec 2013
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 9 Dec 2013
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 6 Dec 2013
Auxilium Announces U.S. Food and Drug Administration Approval for XIAFLEX(R) for the Treatment of Peyronie's Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Nov 2013
GW Pharmaceuticals plc Announces Sativex(R) Regulatory Approval in Switzerland
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 25 Nov 2013
Auxilium Pharmaceuticals Presented New Analyses of XIAFLEX(R) Peyronie's Disease Data at SMSNA Scientific Meeting
Biopharmaceuticals Urology
 HSMN NewsFeed - 18 Nov 2013
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
Biopharmaceuticals
 HSMN NewsFeed - 18 Nov 2013
BiO2 Medical Executes Q4 2013 Commercialization Strategy for the Angel(R) Catheter, Signing Distribution Partnership Agreements in Key European and Middle Eastern Geographies
Devices Distribution
 HSMN NewsFeed - 28 Oct 2013
APR Applied Pharma Research (APR) announces the European CE approval for Nexodyn(R), a newly developed product for the management of acute and chronic wounds
Biopharmaceuticals Wound Care Regulatory
 HSMN NewsFeed - 11 Oct 2013
Auxilium Pharmaceuticals, Inc. Announces License Agreement For The Marketing Rights To STENDRA(TM) In The United States And Canada
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Oct 2013
VeriTeQ Partner Establishment Labs Receives CE Mark Approval to Market Motiva Implant Matrix Ergonomix Breast Implant with VeriTeQ’s Q Inside Safety Technology
Devices Regulatory
 HSMN NewsFeed - 7 Oct 2013
Auxilium Pharmaceuticals, Inc. Presented Data At The ASSH Annual Meeting About XIAFLEX(R) For The Treatment Of Dupuytren's Contracture
Biopharmaceuticals Othopaedic
 HSMN NewsFeed - 11 Sep 2013
invendo medical Appoints Chief Operating And Chief Technology Officer
Devices Gastroenterology Personnel
 HSMN NewsFeed - 28 Aug 2013
Grifols and Aradigm Corporation Complete the Closing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin(R)
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 28 Aug 2013
Auxilium Receives Notification of XIAFLEX(R) PDUFA Extension
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Aug 2013
Alexza Announces Management Promotions
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 30 Jul 2013
Alexza Pharmaceuticals Announces European Launch of ADASUVE(R) (Staccato(R) Loxapine)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 25 Jul 2013
Aerie Pharmaceuticals Names Vicente Anido, Jr., Current Chairman of the Board, as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 10 Jul 2013
Tris Pharma's Generic Pharmaceuticals Business Launches Dextroamphetamine Sulfate Oral Solution
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 8 Jul 2013
GW Pharmaceuticals plc Announces Sativex(R) Launch in Italy
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 2 Jul 2013
Mentor Announces Collaboration Agreement With Valeant Pharmaceuticals
Devices Distribution
 HSMN NewsFeed - 20 Jun 2013
Tris Pharma Hires President for Generic Pharmaceuticals Business
Biopharmaceuticals Generics Drug Delivery Personnel
 HSMN NewsFeed - 12 Jun 2013
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 May 2013
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Apr 2013
Teva Establishes Global Specialty Medicines Group
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2013
Nuvo Research announces European launch of Pliaglis(R) by Galderma
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 3 Apr 2013
Monteris Medical's AutoLITT- NeuroBlate System for Brain Tumors Receives Regulatory Approval in Canada
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 21 Mar 2013
Takeda Launches New Subsidiary in Ecuador
Biopharmaceuticals
 HSMN NewsFeed - 11 Mar 2013
invendo medical Announces US Market Entry Following Special 510(k) Clearance By FDA For Computer-Assisted Single-Use Colonoscopy System
Devices Gastroenterology
 HSMN NewsFeed - 25 Feb 2013
First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
Devices
 HSMN NewsFeed - 21 Feb 2013
Alexza Receives Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Jan 2013
Baxter Announces Agreement to Acquire Investigational Hemophilia Compound OBI-1 and Related Assets
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 Jan 2013
Auxilium Pharmaceuticals, Inc. Announces Expansion of Its Exclusive License for XIAFLEX(R) (CCH) to Include the Potential Treatment of Cellulite as an Additional Indication
Biopharmaceuticals
 HSMN NewsFeed - 3 Jan 2013
Alphatec Spine Receives U.S. FDA 510(K) Market Clearance for Two New Products and Receives Japanese Shonin Approval to Begin Marketing Its Novel(R) Peek Lumbar Spinal Spacers
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 3 Jan 2013
Sensimed AG Receives a New Reimbursement Code in the USA by the AMA for Intraocular Pressure Monitoring
Devices Reimbursement Ophthalmology
 HSMN NewsFeed - 27 Dec 2012
John Norris, JD, MBA Appointed CEO of Health Discovery Corporation
Diagnostics Personnel Personalized Medicine
 HSMN NewsFeed - 27 Dec 2012
U.S. Food and Drug Administration Accepts XIAFLEX(R) Supplemental Biologics License Application Filing for the Treatment of Peyronie's Disease
Biopharmaceuticals Urology
 HSMN NewsFeed - 19 Dec 2012
Minimally Invasive Hybrid Ablation Procedure Demonstrates Significant Benefits for the Treatment of Atrial Fibrillation
Devices Cardiology
 HSMN NewsFeed - 14 Dec 2012
The CHMP Delivers a Positive Opinion Recommending Grant of Marketing Authorization for ADASUVE(R) (Staccato(R) Loxapine) in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Dec 2012
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 29 Nov 2012
Rib-X Pharmaceuticals Closes First Tranche in $67.5 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Nov 2012
Constella(R) (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 27 Nov 2012
Kala Pharmaceuticals Appoints Dr. Bernard Gilly to Its Board of Directors
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 15 Nov 2012
Tris Pharma Appoints New Vice President of Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 28 Oct 2012
IBA and Philips Announce First Installation of Patient-Centered Proton Treatment Room
Devices Oncology
 HSMN NewsFeed - 23 Oct 2012
IBA to Showcase Its Full Spectrum of Proton Therapy Solutions and Services at the American Society for Radiation Oncology (ASTRO) Conference
Devices Oncology
 HSMN NewsFeed - 22 Oct 2012
Nuvo and Galderma Announce FDA Approval of Pliaglis(R)
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 27 Sep 2012
Alphatec Spine Receives Board Approval to Acquire Assets of Spine Implant Business
Devices Orthopaedic Neurosurgery Acquisitions
 HSMN NewsFeed - 24 Sep 2012
Nodality, Inc. Appoints Laura Brege as Chief Executive Officer
Personalized Medicine Personnel
 HSMN NewsFeed - 24 Sep 2012
QLT Announces Sale of Visudyne(R) to Valeant Pharmaceuticals
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 20 Sep 2012
Innovative Ultrasound Company SuperSonic Imagine Receives FDA Clearance to Enhance ShearWave(TM) Elastography Imaging with a Real-Time Adjustable Numerical Scale (ANS)
Devices FDA
 HSMN NewsFeed - 18 Sep 2012
Alphatec Spine Releases Alphatec NEXoss(TM) Nanostructure Bio-Active Matrix and Announces the First Patient Implant
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 13 Sep 2012
Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Sep 2012
Auxilium Pharmaceuticals, Inc. Announces 30 Month XIAFLEX(R) Safety Update
Biopharmaceuticals
 HSMN NewsFeed - 23 Aug 2012
Alphatec Spine Launches New MIS Device, the BridgePoint(TM) Spinous Process Fixation System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 17 Aug 2012
Ranbaxy Launches Authorized Generic Of Pioglitazone In The U.S.
Biopharmaceuticals Generics Endocrinology
 HSMN NewsFeed - 31 Jul 2012
Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
Diagnostics Personalized Medicine Gastroenterology
 HSMN NewsFeed - 11 Jul 2012
MAQUET Sets up New International Marketing and Service Organizations
Devices Cardiology
 HSMN NewsFeed - 22 Jun 2012
Theratechnologies Provides Regulatory Update on Tesamorelin
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Jun 2012
Neurotech s.a. Announces European CE Mark Approval for the ADNS-300 System to Treat Refractory Epilepsy
Devices Neurology Regulatory
 HSMN NewsFeed - 23 May 2012
APP Pharmaceuticals Acquires Three Products from Nexus
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 21 May 2012
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim(R) in the U.S.
Biopharmaceuticals Urology
 HSMN NewsFeed - 16 May 2012
STENTYS Self-Apposing(R) Stent shows very low mortality at one month in 1,000 high-risk heart attack patients
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2012
STENTYS Expands Its Product Offerings for Treating Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 10 May 2012
RXi Pharmaceuticals Appoints Industry Veteran Dr. Geert Cauwenbergh as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2012
Gentium Appoints PharmaSwiss, S.A. as Exclusive Distributor of Defibrotide in Central and Eastern European Countries
Biopharmaceuticals Distribution
 HSMN NewsFeed - 23 Apr 2012
Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
Diagnostics Personnel
 HSMN NewsFeed - 23 Apr 2012
Heart Failure Patients Demonstrate Impressive Improvement With Novel, Less Invasive Technique Using BioVentrix Therapy
Devices Cardiology
 HSMN NewsFeed - 13 Apr 2012
Rib-X Pharmaceuticals Appoints Infectious Disease Expert and Former FDA Deputy Director Matthew Wikler, MD as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2012
Takeda to Acquire URL Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Apr 2012
ETView Medical, Ltd. and Medutech S.A. DE C.V. (Medutech) Execute Distribution Agreement
Devices Distribution
 HSMN NewsFeed - 2 Apr 2012
NicOx appoints Philippe Masquida EVP, Managing Director of European Operations ; Next step in the Company's strategy to create an international ophthalmology company
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 29 Mar 2012
Misonix Announces New Distribution Agreement for Ecuador
Devices Distribution
 HSMN NewsFeed - 21 Mar 2012
Alphatec Spine Appoints New Vice President of Operations
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 21 Mar 2012
Jerry St. Peter appointed Executive Vice President and General Manager of NicOx Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2012
QLT Receives Orphan Drug Designation for Visudyne for Treatment of Central Serous Chorioretinopathy
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 24 Feb 2012
invendo medical Announces 510(k) Clearance by FDA for Advancement-Assisted Single-Use Colonoscopy System
Devices Gastroenterology FDA
 HSMN NewsFeed - 24 Feb 2012
Forest Laboratories Receives European Marketing Approval for Colobreathe(R) Dry Powder Inhaler
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Feb 2012
Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX(R) in Canada, Australia, Brazil and Mexico
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2012
Pliaglis(R) Regulatory Update
Biopharmaceuticals
 HSMN NewsFeed - 6 Feb 2012
Auxilium Announces Appointments to Enhance Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2012
Prometheus Announces New Chief Commercial Officer
Diagnostics Personnel
 HSMN NewsFeed - 20 Jan 2012
Remicade(R) (Infliximab) Receives Positive Opinion From CHMP In Europe for Treatment of Ulcerative Colitis in Pediatric Patients
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 9 Jan 2012
BG Medicine, Inc. Appoints Eric Bouvier as Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 8 Dec 2011
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2011
Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX(R) Study for Frozen Shoulder Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 16 Nov 2011
Alphatec Spine Appoints New Senior Vice President, Global Marketing and Asia Pacific
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 28 Sep 2011
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 21 Sep 2011
STENTYS Completes Enrollment of APPOSITION III Study for its Self-Apposing Stent to Treat Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX(R) Multi-Cord Study
Biopharmaceuticals
 HSMN NewsFeed - 6 Sep 2011
Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX(R) Safety Update
Biopharmaceuticals
 HSMN NewsFeed - 9 Aug 2011
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2011
Alphatec Spine, Inc. Receives Japanese Regulatory Shonin Approval for Illico SE(TM) Posterior Fixation Percutaneous Screw System for Minimally Invasive Surgery
Devices Neurosurgery Orthopaedic Regulatory
 HSMN NewsFeed - 25 May 2011
Watson Acquires Specifar Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Apr 2011
Alphatec Holdings Announces Appointment of Patrick Ryan as Chief Operating Officer
Devices Neurosurgery Orthopaedic Personnel
 HSMN NewsFeed - 21 Apr 2011
Misonix Announces New Distribution Agreement for Colombia
Devices Surgery Distribution
 HSMN NewsFeed - 11 Apr 2011
Auxilium Pharmaceuticals, Inc. Announces Launch of XIAPEX(R) in EU by Pfizer
Biopharmaceuticals
 HSMN NewsFeed - 4 Apr 2011
Alphatec Spine Receives 510(k) Clearance for Its Solus(TM) Anterior Lumbar Interbody Fusion System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 29 Mar 2011
Alphatec Spine Announces the Addition of Leslie H. Cross to Its Board of Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 17 Mar 2011
STENTYS Expands Operations into Four Additional European Countries
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 16 Mar 2011
Fujifilm Submits 510(K) Application to FDA for Aspire HD FFDM System
Devices Radiology Oncology FDA
 HSMN NewsFeed - 16 Feb 2011
Zimmer Showcases Newly Acquired Line of Surgical Power Tools at 2011 AAOS Annual Meeting
Devices Orthopaedic Surgery
 HSMN NewsFeed - 3 Feb 2011
Theratechnologies and Ferrer Announce a Distribution & Licensing Agreement for Tesamorelin in Europe
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 1 Feb 2011
Valeant Pharmaceuticals to Acquire PharmaSwiss S.A.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Jan 2011
Dyax and Sigma-Tau Group Expand Agreement to Commercialize KALBITOR(R) (ecallantide) for Hereditary Angioedema
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Jan 2011
Alphatec Spine, Inc. Announces the First Three-Level Guided Lumbar Interbody Fusion Procedure Performed Using the Revolutionary ARC(TM) Portal Access System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 22 Dec 2010
Zimmer Announces Acquisition of SoPlus Orthopaedic Surgical Power Tools Company
Devices Orthopaedic Surgery Mergers & Acquisitions
 HSMN NewsFeed - 16 Dec 2010
Watson and Richter Announce Exclusive License Agreement for Esmya
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Dec 2010
STENTYS begins large-scale, "real life" study with its self-apposing stent for treatment of Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Nov 2010
Canon U.S.A.’s Newest Retinal Camera, the CR-2 Digital Non-Mydriatic Digital Retinal Camera, Receives FDA Clearance
Devices Ophthalmology FDA
 HSMN NewsFeed - 16 Nov 2010
IBA and ProCure Set Record on Development of Second Proton Therapy Center
Devices Oncology
 HSMN NewsFeed - 10 Nov 2010
Small Bone Innovations International S.A.S. Enters into an Exclusive Distribution Agreement with Biomet Nederland B.V.
Devices Orthopaedic Distribution
 HSMN NewsFeed - 3 Nov 2010
Questcor Pharmaceuticals Launches Acthar for the Treatment of Infantile Spasms
Biopharmaceuticals
 HSMN NewsFeed - 2 Nov 2010
Alphatec Spine Appoints New Senior Vice President, Global Human Resources
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 11 Oct 2010
Alphatec Holdings Announces Appointment of Michael O'Neill, FCMA, as Chief Financial Officer
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 11 Oct 2010
NovaBay Pharmaceuticals Appoints Gail Maderis, BayBio President and CEO and Former Genzyme Senior Executive, to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2010
Alphatec Spine, Inc. Releases PureGen(TM) Osteoprogenitor Cell Allograft to Facilitate Bone Regeneration and Announces First Patient Procedure Performed in the World
Devices Regenerative Medicine Orthopaedic Neurosurgery
 HSMN NewsFeed - 9 Aug 2010
Talecris Biotherapeutics and Grifols Receive FTC Request for Additional Information Regarding Proposed Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Jul 2010
Stellar Pharmaceuticals Inc. Signs Agreement for Distribution and Sale of Uracyst(R) in Spain
Biopharmaceuticals Distribution
 HSMN NewsFeed - 22 Jul 2010
FDA provides Complete Response Letter to NicOx's New Drug Application for naproxcinod
Biopharmaceuticals
 HSMN NewsFeed - 14 Jul 2010
CardioGenics And Merck In Second Product Agreement
Diagnostics Cardiology
 HSMN NewsFeed - 7 Jul 2010
MonoSol Rx Announces FDA Approval of Zuplenz(R) Oral Soluble Film for Treatment of Nausea and Vomiting
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 23 Jun 2010
Stryker Announces Election of New Director
Devices Orthopaedic Personnel
 HSMN NewsFeed - 18 Jun 2010
Lonnel Coats Appointed President & Chief Executive Officer of Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2010
NicOx provides update on FDA Advisory Committee Meeting for naproxcinod
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 May 2010
Alphatec Spine Adds New Vice President and General Manager, Latin America
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 5 May 2010
Frank C. Condella, Jr. Appointed President and Chief Executive Officer of Columbia Laboratories
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2010
Fujitani Takes the Helm at FUJIFILM Medical Systems U.S.A.
Devices Personnel
 HSMN NewsFeed - 27 Apr 2010
AMAG Pharmaceuticals, Inc. Appoints Gary J. Zieziula as Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2010
CE Certification Granted for IBA's 2nd Generation Pencil Beam Scanning Proton Treatment System
Devices Oncology Regulatory
 HSMN NewsFeed - 13 Apr 2010
Galen Partners Invests in Nautilus Neurosciences, Inc.
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 5 Apr 2010
The Canon CX-1 Hybrid Mydriatic/Non-Mydriatic Digital Retinal Camera Receives FDA Clearance
Devices Ophthalmology FDA
 HSMN NewsFeed - 29 Mar 2010
Pro-Pharmaceuticals Licenses to PROCAPS S.A. Exclusive Marketing and Distribution Rights to Commercialize DAVANAT(R) to Treat Cancer in Colombia, South America
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 24 Mar 2010
ondansetron RapidFilm(TM) Approved in 16 European Countries
Biopharmaceuticals Drug Delivery Oncology Regulatory
 HSMN NewsFeed - 24 Mar 2010
Gardner Named President/CEO at EuroMed
Devices Wound Care Personnel
 HSMN NewsFeed - 12 Mar 2010
Medtronic Starts International Study of CoreValve(R) Transcatheter Aortic Valve System
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Mar 2010
CardioGenics Announces Further Update Regarding Status of Merck Agreement
Diagnostics
 HSMN NewsFeed - 4 Mar 2010
IVAX Diagnostics' Diamedix Subsidiary Signs Three Year Exclusive Distribution Agreement with Fumouze Diagnostics
Diagnostics Distribution
 HSMN NewsFeed - 3 Mar 2010
NicOx and Bausch & Lomb Announce Worldwide Licensing Agreement for NCX 116
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 25 Feb 2010
Alphatec Spine Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Scient'x Groupe S.A.S.
Devices Neurosurgery Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 22 Feb 2010
Memometal Technologies Acquires OrthoGlide Ankle Technology From Advanced Bio-Surfaces, Inc.
Devices Orthopaedic Acquisitions
 HSMN NewsFeed - 12 Jan 2010
EuroMed Names Tormey to Board of Directors
Devices Wound Care Personnel
 HSMN NewsFeed - 11 Jan 2010
Stem Cell Company t2cure Appoints Dr Petra Rueck and Susanne Knigge as Co-CEOs
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Jan 2010
Forest and Almirall Announce Positive Results from the ACCORD COPD I Phase III Study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals
 HSMN NewsFeed - 31 Dec 2009
Canon U.S.A. Appoints Chris Duca President of Wholly-Owned Subsidiary Virtual Imaging
Devices Radiology Personnel
 HSMN NewsFeed - 23 Dec 2009
Forest Laboratories Announces Acquisition of Additional Rights Related to NXL 104, a Novel Broad-Spectrum Beta-Lactamase Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Nov 2009
Cellerix Raises EUR27 Million in a First Closing
Regenerative Medicine Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Oct 2009
Activaero Closes a 10.7 Million ($16 million) Series A Financing
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 26 Oct 2009
New Data Presented From WELCOME Trial Show Positive Impact of CIMZIA(R) (certolizumab pegol) on Hospitalizations and Surgeries in Patients With Prior Infliximab Failure
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 23 Oct 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Oct 2009
AccuVein Signs Multiple-Country Distribution Agreement in Europe for Vein Illumination Device
Devices Distribution
 HSMN NewsFeed - 19 Oct 2009
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2009
Biocartis Raises EUR10 Million in Series A Financing Round
Diagnostics Venture Capital
 HSMN NewsFeed - 1 Oct 2009
Scient'x Announces Strategic Alliance In Dynamic Fusion with Allegheny General Hospital
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 28 Sep 2009
MSD Receives Positive CHMP Opinion for 'Januvia(R)' and 'Janumet(R)' as Add-On to Insulin in the European Union
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 23 Sep 2009
ImThera Medical Completes Development of Targeted Hypoglossal Neurostimulation Treatment for OSA
Devices
 HSMN NewsFeed - 23 Sep 2009
EDAP Enhances Ablatherm-HIFU European Marketing Strategy
Devices Oncology
 HSMN NewsFeed - 15 Sep 2009
European Union Commission Approves Expanded Use of ISENTRESS(R) (raltegravir), from MSD, in Adult Patients with HIV-1 Infection
Biopharmaceuticals Regulatory HIV/AIDS
 HSMN NewsFeed - 3 Sep 2009
Dainippon Sumitomo Pharma to Acquire Sepracor for U.S. $23.00 Per Share in an All-Cash Tender Offer Valued at Approximately U.S. $2.6 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Aug 2009
Marketing Application for Vernakalant Intravenous (IV) Filed in Europe for the Treatment of Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 18 Aug 2009
Kolltan Pharmaceuticals Expands Board of Directors and Senior Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Aug 2009
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2009
Valeant to Acquire Tecnofarma, A Mexican Generic Company
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 7 Jul 2009
Alphatec Spine, Inc. Enters Agreement with International Spinal Innovations, LLC
Devices Neurosurgery Orthopaedic Licensing
 HSMN NewsFeed - 2 Jul 2009
Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 1 Jul 2009
Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jun 2009
ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2009
Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 15 May 2009
PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2009
UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 May 2009
PLC Systems Announces First Distribution Agreement in Spain for RenalGuard(R)
Devices Distribution
 HSMN NewsFeed - 4 May 2009
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 1 May 2009
Tepha Partner Launches Novel Monofilament Absorbable Suture Utilizing Tepha's Proprietary Biomaterial
Devices Surgery
 HSMN NewsFeed - 25 Mar 2009
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 23 Mar 2009
Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Mar 2009
Oxygen Biotherapeutics, Inc. Receives Letter From FDA Outlining Path Forward to Resume Oxycyte Clinical Trials in TBI in U.S.A.
Devices FDA
 HSMN NewsFeed - 19 Mar 2009
Oragenics, Inc. Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2009
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Feb 2009
Flamel Technologies Announces Appointment of Jeffery S. Vick as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 19 Feb 2009
European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Feb 2009
Eisai and Bial Announce Partnership Agreement for the European Commercialisation of the Novel Once Daily Anti-Epileptic Zebinix(R)
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 18 Feb 2009
Small Bone Innovations, Inc. Announces Establishment of Small Bone Innovations Deutschland GmbH
Devices Orthopaedic Personnel
 HSMN NewsFeed - 17 Feb 2009
CorNova(R) Expands Management Team with Appointment of Robert Gallahue as Chief Financial Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 13 Feb 2009
SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus
Devices Diagnostics Oncology Distribution
 HSMN NewsFeed - 22 Dec 2008
 Flamel Technologies Announces New Micropump and Medusa Contracts, and a Research Collaboration with Pfizer
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 14 Dec 2008
FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Nov 2008
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2008
GARDASIL®, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Nov 2008
Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding - Debiopharm Submits Response to the FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Oct 2008
Environmental Tectonics Corporation's BioMedical Systems Division Places Two Monoplace Chambers at East Orange (NJ) General Hospital
Devices Wound Care
 HSMN NewsFeed - 27 Oct 2008
CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
Biopharmaceuticals
 HSMN NewsFeed - 14 Oct 2008
Scient'x Announces Relocation and Expansion Plans
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 13 Oct 2008
Theron Odlaug, Ph.D. Promoted to Chief Executive Officer at CyDex Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2008
Scient'x Strengthens Global Management Team
Devices Neurosurgery Orthopaedic Personnel
 HSMN NewsFeed - 6 Oct 2008
CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 25 Sep 2008
Acusphere, Inc. Appoints Michael Slater SVP Regulatory Affairs and Operations Replacing Dennis Bucceri
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2008
Recent Research Shows Significant Benefits in Acute Ischaemic Stroke With Actilyse(R) Beyond Currently Approved Three Hour Treatment Window
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Sep 2008
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Sep 2008
Scient'x Launches Tribeca(TM) TLIF Cage System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 15 Sep 2008
NicOx announces second naproxcinod pivotal phase 3 study (302) meets efficacy primary endpoints and supports non-detrimental blood pressure effect
Biopharmaceuticals
 HSMN NewsFeed - 15 Sep 2008
Alcon Launches New AcrySof(R) ReSTOR(R) Intraocular Lens for Presbyopia Outside the U.S.
Devices Ophthalmology
 HSMN NewsFeed - 12 Sep 2008
Alcon Expands Refractive Surgery Options with the Introduction of the AcrySof(R) Phakic Intraocular Lens Outside the U.S.
Devices Ophthalmology
 HSMN NewsFeed - 3 Sep 2008
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Sep 2008
Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals
 HSMN NewsFeed - 27 Aug 2008
BioAlliance Pharma SA appoints Pierre MORGON Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Aug 2008
Bausch & Lomb Names Presidents for Europe, Middle East, & Africa and Asia Pacific Regions
Devices Ophthalmology Personnel
 HSMN NewsFeed - 29 Jul 2008
European Commission Grants Marketing Authorization for MediGene's Drug Oracea
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 28 Jul 2008
Head-to-head Study Results Demonstrated No Significant Difference Between NicoDerm(R) CQ(R) and Chantix (Varenicline Tartrate) in Long Term Quit Rates
Biopharmaceuticals
 HSMN NewsFeed - 25 Jul 2008
Eisai Receives Action Letter on Fospropofol Disodium Injection for Sedation in Diagnostic or Therapeutic Procedures
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jul 2008
Carl Zeiss Meditec Reaches 1,000 Cirrus(TM) HD-OCT Placements
Devices Ophthalmology
 HSMN NewsFeed - 16 Jul 2008
BioAlliance Pharma suspends the Phase II/III trial of doxorubicin Transdrug(R) in primary liver cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Jul 2008
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
Biopharmaceuticals Distribution
 HSMN NewsFeed - 11 Jul 2008
Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 11 Jul 2008
TREDAPTIVE(TM) (nicotinic acid /laropiprant) Approved in the European Union: New Lipid-Modifying Therapy to Treat LDL-C, HDL-C and Triglycerides
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 9 Jul 2008
Gen-Probe Does Not Intend to Increase Offer to Acquire Innogenetics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 8 Jul 2008
Novartis Completes Purchase of Minority Interest in Alcon
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 8 Jul 2008
Novartis completes acquisition of 25% stake in Alcon from Nestlé, first step toward majority ownership of the world leader in eye care
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 1 Jul 2008
Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Jun 2008
Alcon Enters Into Patent Cross-Licensing Agreement With AMO
Devices Ophthalmology Licensing
 HSMN NewsFeed - 23 Jun 2008
BioAlliance Pharma extends its Loramyc(TM) License to China with NovaMed Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Jun 2008
Sepracor Announces Phase III Data for Eslicarbazepine Acetate Presented at Ninth Eilat Conference on New Anti-Epileptic Drugs
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Jun 2008
Two-Year Clinical Trial Findings Show Significant and Persistent Reduction in Blood Pressure with CVRx(R) Rheos(R) Hypertension Therapy
Devices
 HSMN NewsFeed - 13 Jun 2008
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2008
New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2008
Otsuka and UCB agreed to co-develop and co-promote Keppra(R) and Cimzia(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2008
US FDA grants pediatric exclusivity for UCB's Keppra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jun 2008
Ipsen to Acquire Tercica
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Jun 2008
Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 2 Jun 2008
Data from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial Chemotherapy Presented at 44th ASCO Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 May 2008
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 20 May 2008
Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 May 2008
Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
Biopharmaceuticals
 HSMN NewsFeed - 6 May 2008
Scient'x Announces FDA 510(K) Clearance for Isobar DUO(TM) Dynamic Stabilization System
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 5 May 2008
Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President, Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2008
Timothy F. Floeder Joins Synovis Life Technologies as Vice President of Corporate Development
Devices Surgery Personnel
 HSMN NewsFeed - 5 May 2008
Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva(R) in the Treatment of Psoriasis Published in the British Journal of Dermatology
Biopharmaceuticals
 HSMN NewsFeed - 25 Apr 2008
Neupro(R) recommended for approval in Europe for Restless Legs Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2008
Scient'x Re-Acquires Isobar License
Devices Neurosurgery Orthopaedic Licensing
 HSMN NewsFeed - 24 Apr 2008
Alphatec Holdings, Inc. Terminates License for DYNAMO Semi Rigid Rod System
Devices Neurosurgery Orthopaedic Licensing
 HSMN NewsFeed - 23 Apr 2008
Oculus Innovative Sciences Appoints Michelle Carpenter, JD, RAC, as Vice President of Regulatory Affairs and Quality
Biopharmaceuticals Wound Care Personnel
 HSMN NewsFeed - 22 Apr 2008
Cimzia(R) Approved in the US for the Treatment of Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 21 Apr 2008
Pfizer Japan Receives Manufacturing and Marketing Authorization for SUTENT
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Apr 2008
Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2008
Synergetics USA, Inc. Initiates Antitrust Lawsuit against Alcon, Inc.
Devices Ophthalmology Litigation
 HSMN NewsFeed - 17 Apr 2008
New Data Confirm Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Sleep Disturbance for People With Restless Legs Syndrome (RLS)
Biopharmaceuticals
 HSMN NewsFeed - 16 Apr 2008
European Regulatory Agency Grants Orphan Status to Morphotek(R)'s Farletuzumab and MORAb-009
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Apr 2008
Novartis to further strengthen its healthcare portfolio by acquiring 25% stake in Alcon from Nestlé with right to take over majority ownership of the world leader in eye care
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 4 Apr 2008
Carl Zeiss Meditec Delivers Key Technological Advances in Optical Coherence Tomography
Devices Ophthalmology
 HSMN NewsFeed - 2 Apr 2008
Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 Mar 2008
Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 Mar 2008
BioAlliance Pharma Expands Its Loramyc(TM) Franchise by Signing a South East Asia Deal Worth up to $12 Million with the Leading Korean Pharma Company Handok
Biopharmaceuticals Licensing
 HSMN NewsFeed - 26 Mar 2008
BioAlliance Pharma Receives Market Approval for Loramyc(R) in Germany, Belgium and Luxemburg
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Mar 2008
CHMP Upholds Negative Opinion for the EU Application for Cimzia(R) in the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 20 Mar 2008
UCB advises US-physicians to down-titrate patients on Neupro(R) in view of out-of-stock situation in the US
Biopharmaceuticals Neurology Product Recall
 HSMN NewsFeed - 19 Mar 2008
Forest Laboratories Announces Resignation of Ivan Gergel, MD
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2008
Merck Serono Launches Cyanokit(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2008
Oculus Innovative Sciences Announces Positive Results From Three Abstracts Evaluating the Use of Microcyn(R) Technology in Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 17 Mar 2008
ReWalk Exoskeleton Helps Paraplegics Walk
Devices
 HSMN NewsFeed - 10 Mar 2008
ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Mar 2008
Alcon Announces Leadership Change to Research and Development Organization
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 8 Mar 2008
Carl Zeiss Meditec Introduces New Humphrey Field Analyzer for Glaucoma Management and Blindness Prevention
Devices Ophthalmology
 HSMN NewsFeed - 7 Mar 2008
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
Biopharmaceuticals Distribution
 HSMN NewsFeed - 5 Mar 2008
PanGenetics Raises 23 Million Euro in Series C Financing to Fund Clinical Advancement of Its Therapeutic Antibody Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Mar 2008
UCB: Early Data on Cimzia(R) from the WELCOME Study Show Efficacy in Infliximab-Refractory Crohn's Disease Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 3 Mar 2008
Vasogen Provides Update on ACCLAIM II Program
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Mar 2008
Changes in UCB's Executive Committee
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2008
FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2008
Ambrilia Announces the Departure of Dr. Chandra J. Panchal, Executive Vice-President, Business Development, Licensing and IP
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2008
Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
Biopharmaceuticals
 HSMN NewsFeed - 27 Feb 2008
Oculus Innovative Sciences Announces Positive Top-Line Phase II Data with Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 26 Feb 2008
CryoCath Appoints New Chief Financial Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 26 Feb 2008
Misonix Announces Initial Sales into Ecuador
Devices
 HSMN NewsFeed - 26 Feb 2008
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 26 Feb 2008
Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 25 Feb 2008
BioAlliance Pharma to Pursue Its Strategy for the Targeted Acquisition of Complementary Products Following the Announcement of the Discontinuation of Immtech Pharmaceuticals' Pafuramidine Program
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2008
FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Feb 2008
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Feb 2008
FDA Agrees to Review Cimzia(R) File for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Jan 2008
Solvay Pharmaceuticals, Inc. Announces Retirement of CEO Laurence Downey and Appointment of Stephen Hill as New President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jan 2008
Eisai Completes Acquisition of MGI PHARMA
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Jan 2008
Scient'x, S.A. Appoints Veteran Spinal Orthopedic Industry Executive Michael D. Huggins as President and Chief Executive Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 22 Jan 2008
Taro Receives FDA Approval of New Drug Application for Flo-Pred(TM) (Prednisolone Acetate Oral Suspension)
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jan 2008
Novexel and Forest Laboratories Announce License Agreement for NXL 104, a Novel Broad-Spectrum Beta Lactamase Inhibitor
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Jan 2008
Eisai and MGI PHARMA Announce Early Termination of HSR Waiting Period for Eisai's Acquisition of MGI PHARMA
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Jan 2008
Oculus Innovative Sciences, Inc. Appoints Gregg Alton to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jan 2008
Recordati Licenses Kentera(R) From Watson Pharmaceuticals Inc. (U.S.A.) for Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Jan 2008
Inspire Announces Its Termination of Bilastine Licensing Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Jan 2008
BioAlliance Pharma Receives Market Approval for Loramyc(R) in the United Kingdom and Denmark
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Jan 2008
Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL
Biopharmaceuticals Generics
 HSMN NewsFeed - 3 Jan 2008
Oculus Innovative Sciences Completes Patient Treatment and Follow-up in Its Phase II Clinical Trial in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 31 Dec 2007
Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Dec 2007
CytoCore Names President, International Operations
Diagnostics Personnel
 HSMN NewsFeed - 21 Dec 2007
ISENTRESS(R) (raltegravir) from MSD, First Integrase Inhibitor, Approved by the European Union Commission
Biopharmaceuticals HIV/AIDS Regulatory
 HSMN NewsFeed - 18 Dec 2007
Oculus Innovative Sciences Announces Completion of Two Randomized Controlled Clinical Trials of Microcyn(R) Technology in China
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 18 Dec 2007
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 18 Dec 2007
RaySearch Laboratories: COMPASS(R) Receives FDA Clearance and is Launched
Devices Radiology FDA
 HSMN NewsFeed - 13 Dec 2007
EDAP Announces First Published Long-Term Study of HIFU for Localized Prostate Cancer
Devices Oncology Urology
 HSMN NewsFeed - 13 Dec 2007
AMAG Pharmaceuticals, Inc. Announces Update on Sinerem(TM) in Europe
Biopharmaceuticals Radiology Regulatory
 HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Restless Legs Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Dec 2007
New Phase III Trial Shows Positive Outcome of lacosamide in Patients with Diabetic Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 10 Dec 2007
Eisai to Acquire MGI PHARMA for $41 Per Share in an All Cash Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Dec 2007
Neupro(R) Filed in Europe for the Treatment of Restless Legs Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Dec 2007
BioAlliance Pharma Acquires the European Commercialization Rights to Pafuramidine for the Treatment of Pneumocystis Carinii Pneumonia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 3 Dec 2007
Integra LifeSciences Announces Acquisition of Dental Businesses
Devices Mergers & Acquisitions
 HSMN NewsFeed - 3 Dec 2007
UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Dec 2007
FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Nov 2007
Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Nov 2007
biospace med Raises $18 Million in Venture Capital Funding
Devices Radiology Venture Capital
 HSMN NewsFeed - 20 Nov 2007
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 19 Nov 2007
Oculus Innovative Sciences Wins Federal Court Ruling in Intellectual Property Rights Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 16 Nov 2007
UCB to Appeal European Negative Opinion on CIMZIA(R) for the Treatment of Patients with Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 15 Nov 2007
Helix BioPharma Corp. announces management changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Nov 2007
Orexo Acquires Biolipox
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Nov 2007
NicOx' naproxcinod phase 3 results presented at American College of Rheumatology
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2007
Alcon Gains All Regulatory Clearances for Acquisition of WaveLight AG
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 30 Oct 2007
Lilly and Glenmark Pharmaceuticals Announce License Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 30 Oct 2007
Successful Exclusion of a Renal Artery Aneurysm (RAA) with Cardiatis FluidSmart 3D Multilayer Stent
Devices Interventional
 HSMN NewsFeed - 27 Oct 2007
IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
Devices Oncology
 HSMN NewsFeed - 26 Oct 2007
UCB Announces Initiation of Phase III Clinical Program for RikeltaTM (brivaracetam) as Adjunctive Treatment in Partial-Onset Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Oct 2007
NicOx opens US headquarters in New Jersey
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2007
Steven Engle Appointed Chairman of XOMA
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2007
Salix Pharmaceuticals Licenses OSMOPREP(TM) To Mayoly-Spindler in France
Biopharmaceuticals Licensing Gastroenterology
 HSMN NewsFeed - 1 Oct 2007
IsoRay Announces Global Strategic Alliance with IBt s.a.
Devices Oncology
 HSMN NewsFeed - 28 Sep 2007
Alcon Gains 76.9 Percent of WaveLight Shares and Will Move Forward with Acquisition
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2007
Merck to Donate Three Million Doses of Gardasil(R), its Cervical Cancer Vaccine, to Support Vaccination Programs in Lowest Income Nations
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Sep 2007
Alcon Receives FDA Decision on RETAANE(R) Suspension for Wet AMD
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 19 Sep 2007
IsoTis - Integra Merger
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 18 Sep 2007
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2007
Carl Zeiss Meditec, Inc. Ships 1,000th OPMI(R) Pentero(R) Surgical Microscope to Loyola University Health System
Devices Neurosurgery
 HSMN NewsFeed - 17 Sep 2007
Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 17 Sep 2007
Oculus Innovative Sciences Provides Update of Phase II Study for Microcyn(R) Technology in Mildly Infected Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 16 Sep 2007
Integra NeuroSciences Launches DuraGen XS Dural Regeneration Matrix
Devices Neurosurgery FDA
 HSMN NewsFeed - 12 Sep 2007
Flamel Technologies Announces Medusa(R) License Agreement with Wyeth Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 10 Sep 2007
Alcon Waives Minimum Acceptance Condition for WaveLight AG
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 10 Sep 2007
Alcon Announces Expansion of Swiss Operations
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 5 Sep 2007
Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 4 Sep 2007
Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 30 Aug 2007
YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Aug 2007
Daiichi Sankyo and Forest Laboratories Sign Letter of Intent for Co-Promotion of AZOR(TM)
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2007
IsoTis Receives FDA Clearance for Accell Family of Products
Devices Orthopaedic FDA
 HSMN NewsFeed - 17 Aug 2007
EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 15 Aug 2007
Oncoscience Ag, the European Partner of Ym Biosciences, Announces Completion of Patient Enrollment in Phase III Brain Cancer Trial of Nimotuzumab
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Aug 2007
Integra LifeSciences and IsoTis to Combine Creating a Global Leader in Orthobiologics
Devices Mergers & Acquisitions
 HSMN NewsFeed - 6 Aug 2007
Immunomedics Appoints Edward T. Wolynic to Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Aug 2007
XOMA Appoints Steven B. Engle President, Chief Executive Officer and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2007
Anika Therapeutics Receives FDA Approval for ELEVESS(TM) Product
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 24 Jul 2007
STD Med, Inc. Moves Forward with its South American Distribution Arm, Blue Sky Medical S.A.
Devices Distribution
 HSMN NewsFeed - 23 Jul 2007
IBA Unveils Its Universal Nozzle for Proton Therapy During AAPM
Devices Oncology
 HSMN NewsFeed - 16 Jul 2007
EDAP Revises Termination Agreement With HealthTronics
Devices Oncology
 HSMN NewsFeed - 12 Jul 2007
Mersana Therapeutics, Inc. Appoints Pharmaceutical Industry Veteran Nicholas G. Bacopoulos, Ph.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2007
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 407

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 407 additional stories matching:
S.A.
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.